IRIS
AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.703
NA - Nord America 1.175
EU - Europa 535
SA - Sud America 97
AF - Africa 18
OC - Oceania 8
Totale 7.536
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.840
US - Stati Uniti d'America 1.125
CN - Cina 497
HK - Hong Kong 223
GB - Regno Unito 143
IT - Italia 140
BR - Brasile 78
DE - Germania 73
VN - Vietnam 66
FI - Finlandia 48
NL - Olanda 38
CA - Canada 28
TR - Turchia 21
IN - India 20
MX - Messico 19
PL - Polonia 16
FR - Francia 14
CZ - Repubblica Ceca 10
ES - Italia 10
JP - Giappone 10
LT - Lituania 10
UA - Ucraina 10
AR - Argentina 8
AU - Australia 8
ZA - Sudafrica 8
AT - Austria 6
ID - Indonesia 5
BD - Bangladesh 4
EC - Ecuador 4
PE - Perù 3
RU - Federazione Russa 3
SE - Svezia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
JO - Giordania 2
MY - Malesia 2
TL - Timor Orientale 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BJ - Benin 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
IQ - Iraq 1
KH - Cambogia 1
LB - Libano 1
ML - Mali 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
VG - Isole Vergini Britanniche 1
YT - Mayotte 1
Totale 7.536
Salva come PNG Salva come JPEG
Città #
Singapore 328
Dallas 265
Ashburn 239
Hong Kong 218
Hefei 206
London 123
Boardman 115
Beijing 110
Shanghai 71
Council Bluffs 59
Munich 56
West Jordan 40
Los Angeles 38
Rome 35
Amsterdam 30
Ho Chi Minh City 30
Santa Clara 26
Turku 26
San Francisco 23
Washington 23
Helsinki 22
Sona 20
Seattle 19
São Paulo 18
Bari 15
Warsaw 15
Ankara 14
Toronto 13
Pune 12
Mexico City 11
Atlanta 10
Brno 10
Brooklyn 10
Tokyo 10
Hanoi 9
New York 9
Boston 8
Changsha 7
Charlotte 7
Chicago 5
Haiphong 5
Milan 5
Montreal 5
Chengdu 4
Chennai 4
Da Nang 4
Duino-Aurisina 4
Haikou 4
Johannesburg 4
Naples 4
Noicattaro 4
Paris 4
State College 4
Brasília 3
Brest 3
Denver 3
Guayaquil 3
Hải Dương 3
Manchester 3
Ninh Bình 3
Philadelphia 3
Phoenix 3
Redmond 3
San Jose 3
Secaucus 3
Sydney 3
The Dalles 3
Vienna 3
Vilnius 3
Amman 2
Canberra 2
Central 2
Charleston 2
Cuernavaca 2
Curitiba 2
Dili 2
Guiyang 2
Handan 2
Herne Bay 2
Honolulu 2
Lima 2
Linyi 2
Melbourne 2
Messina 2
Montesilvano Marina 2
Orem 2
Perugia 2
Resistencia 2
Reus 2
Ribeirão Preto 2
Rio de Janeiro 2
Rockville 2
Santo André 2
Stockholm 2
Tashkent 2
Teresina 2
Tianjin 2
Topeka 2
Tây Ninh 2
Abidjan 1
Totale 2.469
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 211
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 209
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 206
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 204
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 202
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 201
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 201
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 197
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 195
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 192
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 189
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 183
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 182
Leptin in immuno-rheumatological diseases 175
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 113
GH-resistance in different stages of chronic liver disease 111
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 110
Diabetes in chronic liver disease: from old concepts to new evidence 108
Enhanced portal flow velocity and volume following Iloprost treatment 106
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 105
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 103
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 102
Radiofrequency ablation of hepatic tissue: a new experimental animal model 101
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 101
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 98
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 98
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 97
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 96
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 96
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 92
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 91
Cannabinoids in Autoimmune and Rheumatic Diseases 90
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 90
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 90
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 88
Leptin in autoimmune mechanisms of systemic rheumatic diseases 88
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 87
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 85
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 85
ANA testing in ‘real life’ 84
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 83
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 76
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 75
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 73
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 70
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 68
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 66
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 62
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 56
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 52
Pain and Frailty in Hospitalized Older Adults 49
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 48
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 43
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 42
TNF-alpha and growth hormone resistance in patients with chronic liver disease 41
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 38
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 36
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 35
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 35
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 35
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 35
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 35
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 35
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 35
The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study 34
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 34
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 33
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 33
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 33
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 33
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 33
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 32
Matters of the heart: The case of TNF-alpha targeting drugs 32
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 31
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 31
Utility of ultrasound in the diagnosis of chronic worsened gout 30
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 30
Surgical complications after resection of adrenal carcinoma 30
Phase angle could be a marker of microvascular damage in systemic sclerosis 30
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 29
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 29
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 29
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 28
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 28
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 28
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 28
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 27
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 27
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 27
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 27
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 26
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 26
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 26
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 25
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 25
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 25
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 24
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 24
Serum level of endostatin and digital ulcers in systemic sclerosis patients 24
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 24
Totale 7.520
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/20261.376 324 193 331 267 158 103 0 0 0 0 0 0
Totale 7.602